Stellate Ganglion Blockade: an Intervention for the Management of Ventricular Arrhythmias.
Journal Article (Journal Article;Review)
PURPOSE OF REVIEW: To highlight the indications, procedural considerations, and data supporting the use of stellate ganglion blockade (SGB) for management of refractory ventricular arrhythmias. RECENT FINDINGS: In patients with refractory ventricular arrhythmias, unilateral or bilateral SGB can reduce arrhythmia burden and defibrillation events for 24-72 h, allowing time for use of other therapies like catheter ablation, surgical sympathectomy, or heart transplantation. The efficacy of SGB appears to be consistent despite the type (monomorphic vs polymorphic) or etiology (ischemic vs non-ischemic cardiomyopathy) of the ventricular arrhythmia. Ultrasound-guided SGB is safe with low risk for complications, even when performed on anticoagulation. SGB is effective and safe and could be considered for patients with refractory ventricular arrhythmias.
Full Text
- Published version (via Digital Object Identifier)
- Pubmed Central version
- Open Access Copy from Duke
- Link to Item
Duke Authors
- Al-Khatib, Sana Mustapha
- Fudim, Marat
- Ganesh, Arun
- Harpole Jr., David Harold
- Katz, Jason Neil
- Koontz, Jason
- Mathew, Joseph P.
- Piccini Sr., Jonathan Paul
- Ray, Neil Deep
- Sun, Albert Y.
- Tong, Betty Caroline
- Ulloa, Luis
Cited Authors
- Ganesh, A; Qadri, YJ; Boortz-Marx, RL; Al-Khatib, SM; Harpole, DH; Katz, JN; Koontz, JI; Mathew, JP; Ray, ND; Sun, AY; Tong, BC; Ulloa, L; Piccini, JP; Fudim, M
Published Date
- October 23, 2020
Published In
Volume / Issue
- 22 / 12
Start / End Page
- 100 -
PubMed ID
- 33097982
Pubmed Central ID
- PMC7646199
Electronic International Standard Serial Number (EISSN)
- 1534-3111
Digital Object Identifier (DOI)
- 10.1007/s11906-020-01111-8
Language
- eng
Conference Location
- United States